Market Overview

Hospira, Q Core Medical Sign Int'l Distribution Deal for Sapphire System

Related HSP
Pfizer Upgraded At Cowen On 'Compelling' Valuation, Innovation
State Street Global Advisors Announces Impact of Receiving Settlement Payment

Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, and Q Core Medical, Ltd., an innovation leader in infusion delivery systems, today announced that the companies have entered into a distribution agreement for the Q Core Sapphire™ multi-therapy infusion system. Through the arrangement, Hospira will have exclusive rights to market and distribute Sapphire -- a compact and lightweight infusion device system frequently used in ambulatory and hospital settings -- in more than 60 key markets across Europe, Asia and The Americas. The agreement also enables Hospira to collaborate with Q Core for distribution of its product development pipeline.

Posted-In: News Contracts


Related Articles (HSP)

View Comments and Join the Discussion!

Get Benzinga's Newsletters